Span-America Medical Systems, Inc. (NASDAQ: SPAN) announced today that the Board of Directors declared a cash dividend of $12.5 cents ($0.125) per share. The dividend is payable September 5, 2012, to shareholders of record on August 16, 2012. “This dividend will mark our 91 st consecutive quarter of paying cash dividends and highlights our commitment to returning a portion of Span-America’s earnings to shareholders,” stated Jim Ferguson, president and chief executive officer of Span-America. “This dividend also represents a 13.6% increase in the cash dividend compared with the same quarter last year. We believe our long-term record of paying a cash dividend highlights our strong financial position and excellent cash flow from operations through the first nine month of fiscal 2012.” About Span-America Medical Systems, Inc. Span-America manufactures and markets a comprehensive selection of pressure management products for the medical market, including Geo-Matt®, PressureGuard®, Geo-Mattress®, Custom Care®, Span+Aids®, Isch-Dish®, Risk Manager® and Selan® products. We also supply custom foam and packaging products to the consumer and industrial markets. Through our wholly-owned subsidiary Span Medical Products Canada Inc., we manufacture and market the M.C. Healthcare Products brands of Maxxum, Advantage and Rexx bed frames as well as related case goods, tables and seating products for the long-term care market. Span-America’s stock is traded on The NASDAQ Global Market under the symbol “SPAN.” For more information, visit www.spanamerica.com and www.mchealthcare.com.
In this series, we look through the most recent Dividend Channel ''DividendRank'' report, and then we cherry pick only those companies that have experienced insider buying within the past six months. The officers and directors of a company tend to have a unique insider's view of the business, and presumably the only reason an insider would choose to take their hard-earned cash and use it to buy stock in the open market, is that they expect to make money — maybe they find the stock very undervalued, or maybe they see exciting progress within the company, or maybe both.